Metraipolis › archive › dc_e95276d36e5e

Valuation of Medical Innovation in Orphan Diseases with a Focus on Small Investors and Limited Diversifiable Risks — Europe PMC PMID:42647213

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42647213
DOI
10.3390/jmahp14030047
License (as archived)
solo-consultazione
Archived
2026-10-15T17:24:56.371Z
SHA-256 of the archived text
54d708eac4c71d4adc14de4969f87beb49dd9a57f88e35125838637b074ce0cd
Stable URL of this page
https://metraipolis.com/documento/dc_e95276d36e5e

How to cite

Valuation of Medical Innovation in Orphan Diseases with a Focus on Small Investors and Limited Diversifiable Risks — Europe PMC PMID:42647213 — Europe PMC (en), https://europepmc.org/article/MED/42647213 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e95276d36e5e (Metraipolis archive dc_e95276d36e5e, sha256 54d708eac4c71d4adc14de4969f87beb49dd9a57f88e35125838637b074ce0cd)
BibTeX
@misc{dce95276d36e5e,
  title = {Valuation of Medical Innovation in Orphan Diseases with a Focus on Small Investors and Limited Diversifiable Risks — Europe PMC PMID:42647213},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42647213},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e95276d36e5e; sha256 54d708eac4c71d4adc14de4969f87beb49dd9a57f88e35125838637b074ce0cd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42647213. Agents can read the archived copy with the MCP tool read_document.